SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-25-002644
Filing Date
2025-01-10
Accepted
2025-01-10 16:05:25
Documents
15
Period of Report
2025-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227345-8k_optimize.htm   iXBRL 8-K 26371
2 SEPARATION AND ADVISORY AGREEMENT EXECUTED AS OF JANUARY 3, 2025 BY AND BETWEEN ea022734501ex10-1_optimize.htm EX-10.1 76782
3 GRAPHIC ex10-1_001.jpg GRAPHIC 5098
  Complete submission text file 0001213900-25-002644.txt   304772

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE oprx-20250103.xsd EX-101.SCH 3021
5 XBRL LABEL FILE oprx-20250103_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE oprx-20250103_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0227345-8k_optimize_htm.xml XML 3671
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 25522883
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)